TryGOLD- Free

Pfizer Reduces Stake in Haleon to 7.3%
The Wall Street Journal|January 16, 2025
Sale of shares in the British consumer- healthcare business raises $3.05 billion
- By IAN WALKER
Pfizer Reduces Stake in Haleon to 7.3%

Pfizer has sold 700 million shares in British consumer- healthcare business Haleon for £2.5 billion, equivalent to US$3.05 billion.

This story is from the January 16, 2025 edition of The Wall Street Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Pfizer Reduces Stake in Haleon to 7.3%
Gold Icon

This story is from the January 16, 2025 edition of The Wall Street Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

We use cookies to provide and improve our services. By using our site, you consent to cookies. Learn more